JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Journal of Molecular Endocrinology (2004) 33, 663-677    DOI: 10.1677/jme.1.01606
© 2004 Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boelaert, K
Right arrow Articles by McCabe, C J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boelaert, K
Right arrow Articles by McCabe, C J

PTTG’s C-terminal PXXP motifs modulate critical cellular processes in vitro

K Boelaert*, R Yu1,*, L A Tannahill, A L Stratford, F L Khanim, M C Eggo, J S Moore, L S Young2, N J L Gittoes, J A Franklyn, S Melmed1 and C J McCabe

Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK
1 Cedars-Sinai Research Institute, UCLA School of Medicine, Los Angeles, CA 90048, USA
2 Institute for Cancer Studies, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK

(Requests for offprints should be addressed to K Boelaert; Email: k.boelaert{at}bham.ac.uk)

* (K Boelaert and R Yu contributed equally to this work)

Human pituitary tumor-transforming gene (PTTG), known also as securin, is a multifunctional protein implicated in the control of mitosis and the pathogenesis of thyroid, colon, oesophageal and other tumour types. Critical to PTTG function is a C-terminal double PXXP motif, forming a putative SH3-interacting domain and housing the gene’s sole reported phosphorylation site. The exact role of phosphorylation and PXXP structure in the modulation of PTTG action in vitro remains poorly understood. We therefore examined the mitotic, transformation, proliferation and transactivation function of the C-terminal PXXP motifs of human PTTG. Live-cell imaging studies using an EGFP-PTTG construct indicated that PTTG’s regulation of mitosis is retained regardless of phosphorylation status. Colony-formation assays demonstrated that phosphorylation of PTTG may act as a potent inhibitor of cell transformation. In proliferation assays, NIH-3T3 cells stable transfected and overexpressing mutations preventing PTTG phosphorylation (Phos-) showed significantly increased [3H]thymidine incorporation compared with WT, whereas mutants mimicking constitutive phosphorylation of PTTG (Phos+) exhibited reduced cell proliferation. We demonstrated that PTTG transactivation of FGF-2 in primary thyroid and PTTG-null cell lines was not affected by PTTG phosphorylation but was prevented by a mutant disrupting the PXXP motifs (SH3-). Taken together, our data suggest that PXXP structure and phosphorylation are likely to exert independent and critical influences upon PTTG’s diverse actions in vitro.




This article has been cited by other articles:


Home page
 Endocr Relat CancerHome page
F. Salehi, K. Kovacs, B. W Scheithauer, R. V Lloyd, and M. Cusimano
Pituitary tumor-transforming gene in endocrine and other neoplasms: a review and update
Endocr. Relat. Cancer, September 1, 2008; 15(3): 721 - 743.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
G. Vlotides, T. Eigler, and S. Melmed
Pituitary Tumor-Transforming Gene: Physiology and Implications for Tumorigenesis
Endocr. Rev., April 1, 2007; 28(2): 165 - 186.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. A. van de Pavert, J. Meuleman, A. Malysheva, W. M. Aartsen, I. Versteeg, F. Tonagel, W. Kamphuis, C. J. McCabe, M. W. Seeliger, and J. Wijnholds
A Single Amino Acid Substitution (Cys249Trp) in Crb1 Causes Retinal Degeneration and Deregulates Expression of Pituitary Tumor Transforming Gene Pttg1
J. Neurosci., January 17, 2007; 27(3): 564 - 573.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
R. Yu, M. Cruz-Soto, S. L. Calzi, H. Hui, and S. Melmed
Murine pituitary tumor-transforming gene functions as a securin protein in insulin-secreting cells.
J. Endocrinol., October 1, 2006; 191(1): 45 - 53.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
S-Y Chan, J A Franklyn, H N Pemberton, J N Bulmer, T J Visser, C J McCabe, and M D Kilby
Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction.
J. Endocrinol., June 1, 2006; 189(3): 465 - 471.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
D. S. Kim, J. A. Franklyn, A. L. Stratford, K. Boelaert, J. C. Watkinson, M. C. Eggo, and C. J. McCabe
Pituitary Tumor-Transforming Gene Regulates Multiple Downstream Angiogenic Genes in Thyroid Cancer
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 1119 - 1128.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. L. Stratford, K. Boelaert, L. A. Tannahill, D. S. Kim, A. Warfield, M. C. Eggo, N. J. L. Gittoes, L. S. Young, J. A. Franklyn, and C. J. McCabe
Pituitary Tumor Transforming Gene Binding Factor: A Novel Transforming Gene in Thyroid Tumorigenesis
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4341 - 4349.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Society for Endocrinology.